Ethanol
Regulatory activity · FDAAlso known as 1-Hydroxyethane, ALCOHOL, ALCOHOL,ETHYL, Alcohol (ethyl)+20 more
1-Hydroxyethane, ALCOHOL, ALCOHOL,ETHYL, Alcohol (ethyl), Alcohol etílico, Alcohol, Dehydrated, Alcool éthylique, Alkohol, Avagard, DEHYDRATED ALCOHOL, Dehydrated ethanol, EtOH - Ethanol, Ethyl Alcohol, Ethyl Alcohol Topical, Grain alcohol, Hydroxyethane, Methylcarbinol, Spiritus vini, etanol, Äthanol, Äthylalkohol, éthanol, Alcohol anhydrous, anhydrous ethanol.
Recent clinical, regulatory, research and industry developments relating to this drug.
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
Nicotinic Receptor Genetic Variation and Alcohol Reward
A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study
Influence of Orexin Antagonism on Motivation for Alcohol
Role of Metal Ion Transporter ZIP8 in Alcohol Related Behaviors
Chronic alcohol-induced brain states limit propagation of direct cortical stimulation.
Central amygdala astrocyte plasticity underlies GABAergic dysregulation in ethanol dependence.
Astrocyte Extracellular Matrix Modulates Neuronal Dendritic Development.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Effects of Varenicline in Heavy Drinking Smokers
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Alcoholism, clinical and experimental research2
- Scientific reports2
- Translational psychiatry2
- Addiction biology1
- Annals of hepatology1
- Annual review of pharmacology and toxicology1
- Boissoneault J2
- Cortez-Pinto H2
- Fink-Jensen A2
- Klausen MK2
- Loomba R2
- Lovinger DM2
- Stennett B2
- Thomsen M2
- University of Copenhagen3
- Clínica Universitária de Gastrenterologia2
- Department of Clinical and Health Psychology2
- Indiana University School of Medicine2
- Laboratory for Integrative Neuroscience2
- Laboratory of Neuropsychiatry2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 9 of the same disease areas as Ethanol in the shared literature.
Studied across 8 of the same disease areas as Ethanol in the shared literature.
Studied across 6 of the same disease areas as Ethanol in the shared literature.
Studied across 5 of the same disease areas as Ethanol in the shared literature.
Studied across 3 of the same disease areas as Ethanol in the shared literature.
Studied across 2 of the same disease areas as Ethanol in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.